{
    "clinical_study": {
        "@rank": "48650", 
        "arm_group": [
            {
                "arm_group_label": "Intraneural injection", 
                "arm_group_type": "Experimental", 
                "description": "All patients in the arm will receive a single intraneural injection of 12 ml Ropivacaine 1% BBraun, Germany, in the sciatic nerve under echographic guidance."
            }, 
            {
                "arm_group_label": "extraneural injection", 
                "arm_group_type": "Active Comparator", 
                "description": "All patients in the arm will receive a single extraneural injection of 12 ml Ropivacaine 1% BBraun, Germany, around the sciatic nerve under echographic guidance."
            }
        ], 
        "brief_summary": {
            "textblock": "Aim of this study is to demonstrate the advantages of intraneural injection over extraneural\n      injection in terms of onset and duration on peripheral block. In addition we will evaluate\n      the frequency of possible adverse effects."
        }, 
        "brief_title": "Popliteal Sciatic Nerve Block: Intraneural or Extraneural?", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hallux Valgus", 
        "condition_browse": {
            "mesh_term": "Hallux Valgus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA I-II\n\n        Exclusion Criteria:\n\n          -  Neurological diseases\n\n          -  Diabetes\n\n          -  Allergies to used drugs\n\n          -  Chronic pain in treatment\n\n          -  Electrophysiological alterations at time zero analysis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "88", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01987128", 
            "org_study_id": "IOGPGC04-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intraneural injection", 
                "description": "BBraun Ropivacaine 1% 12ml injection divided in each sciatic components under echographic guidance with a PAJUNK SonoPlex 22G needle.", 
                "intervention_name": "Intraneural injection", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "extraneural injection", 
                "description": "BBraun Ropivacaine 1% 12ml extraneural injection around sciatic nerve under echographic guidance with a PAJUNK SonoPlex 22G needle.", 
                "intervention_name": "Extraneural injection", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Intraneural injection", 
                    "extraneural injection"
                ], 
                "intervention_name": "Ropivacaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Intraneural injection", 
                    "extraneural injection"
                ], 
                "intervention_name": "PAJUNK SonoPlex 22G needle.", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 20, 2013", 
        "location": {
            "contact": {
                "email": "gianluca.cappelleri@gpini.it", 
                "last_name": "gianluca cappelleri, MD", 
                "phone": "+390258296297"
            }, 
            "facility": {
                "address": {
                    "city": "Milan", 
                    "country": "Italy", 
                    "state": "Milano", 
                    "zip": "20122"
                }, 
                "name": "Istituto Ortopedico G. Pini"
            }, 
            "investigator": {
                "last_name": "gianluca cappelleri, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Blocco Del Nervo Sciatico al Poplite, Intraneurale o Extraneurale? Confronto Prospettico, Randomizzato in Cieco Tra la modalit\u00e0 di Iniezione di Anestetico Locale Per il Blocco Eco Guidato Del Nervo Sciatico al Poplite Nella Chirurgia Dell'Alluce Valgo", 
        "overall_contact": {
            "email": "gianluca.cappelleri@gpini.it", 
            "last_name": "Gianluca Cappelleri, MD", 
            "phone": "+390258296297"
        }, 
        "overall_official": {
            "affiliation": "Istituto Ortopedico Gaetano Pini", 
            "last_name": "Gianluca Cappelleri, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pinprick test evaluation on sciatic nerve territory:\nWith a 22G needle the blinded operator will assess sensitiveness to puncture and then assign a score every 2 minutes for 30 minutes. A score of 0 will describe no sensation to puncture, on the other hand a score of 1 will be assigned if sensation to puncture is still present.\nEvaluation of motor blockade:\nPlantar and dorsal flexion of the foot will be evaluated for motor blockade of sciatic nerve. A score of 1 will be assigned if foot movement is conserved, 2 if is impaired and 3 when disappears.\nOnset time is described as the time at which pinprick score turns to 0 and motor blockade score turns to 3.", 
            "measure": "onset time", 
            "safety_issue": "No", 
            "time_frame": "every 2 minutes for a maximum of 30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01987128"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Istituto Ortopedico Gaetano Pini", 
            "investigator_full_name": "Gianluca Cappelleri", 
            "investigator_title": "Medical Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Success rate is described as the percentage of subjects with an onset time within 30 minutes in a group among all subjects treated in that group", 
                "measure": "success rate in each group", 
                "safety_issue": "No", 
                "time_frame": "at 30 minutes"
            }, 
            {
                "description": "Neurophysiological and clinic evaluation will be assessed either with clinical examination and electrophysiological tests by a neurophysiologist eventually evidencing any movement impairment or dysesthesia in the sciatic territory.", 
                "measure": "Nerve injuries", 
                "safety_issue": "Yes", 
                "time_frame": "1, 5 weeks and at 6 months after surgery"
            }
        ], 
        "source": "Istituto Ortopedico Gaetano Pini", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Istituto Ortopedico Gaetano Pini", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}